Review
Gene therapy for inherited immunodeficiencies
Affiliations
- PMID: 12901330
Item in Clipboard
Review
Gene therapy for inherited immunodeficiencies
Curr Hematol Rep.
2003 Jul.
Abstract
Extensive research into gene therapy technologies has produced few clinically relevant results. Advances in the understanding of the genetics of inherited immunologic diseases, gene transfer methodologies, and stem cell manipulation have all contributed to successes in treating X-linked severe combined immunodeficiency and adenosine deaminase deficiency. This review examines the progress and the problems that have arisen, and discusses the improvement and future of gene therapy for primary immunodeficiencies.
Similar articles
-
Gene therapy of primary immunodeficiencies.Adv Nephrol Necker Hosp. 1997;26:107-20. Adv Nephrol Necker Hosp. 1997. PMID: 8922128 Review. No abstract available.
-
[Gene therapy for hereditary immunodeficiencies].C R Seances Soc Biol Fil. 1996;190(1):77-93. C R Seances Soc Biol Fil. 1996. PMID: 8881271 Review. French.
-
Gene therapy of severe combined immunodeficiencies.J Gene Med. 2001 May-Jun;3(3):201-6. doi: 10.1002/1521-2254(200105/06)3:3<201::AID-JGM195>3.0.CO;2-Z. J Gene Med. 2001. PMID: 11437325 Review.
-
Primary immunodeficiencies: molecular aspects and treatment.Bone Marrow Transplant. 1992;9 Suppl 1:39-43. Bone Marrow Transplant. 1992. PMID: 1354525 Review. No abstract available.
-
Gene therapy for primary immunodeficiencies.Immunol Allergy Clin North Am. 2008 May;28(2):457-71, xi. doi: 10.1016/j.iac.2008.02.001. Immunol Allergy Clin North Am. 2008. PMID: 18424342 Review.
Cited by
-
A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice.J Virol. 2011 Dec;85(23):12759-68. doi: 10.1128/JVI.00661-11. Epub 2011 Sep 21. J Virol. 2011. PMID: 21937637 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials